Category: Research

On April 13th, 2023, the UCB’s Global Corporate Website released a press statement regarding the RAISE clinical trial of zilucoplan – one of two drugs being reviewed for the treatment of myasthenia gravis. The trial was led by James Howard, MD, who is a neurology professor at the UNC School...

Dr. Li-Ming Hsu, a postdoctoral researcher in Ian Shih’s lab, received a new R21 award from the National Institute of Drug Abuse to study the role of anterior cingulate cortex in nicotine addiction. Dr. Ian Shih received a new R01 award from the National Institute of Neurological Disorders and Stroke with collaborators...

Researchers in the Shih lab published novel findings on causal control of the anterior insular cortex on the default mode network of the brain using selective neural stimulation (Nature Communications, featured as an Editor’s highlight article), and multi-channel optical recording of neural activity changes during fMRI (Science Advances, see also Press release, Video...

A prestigious recognition, the National MS Society awards this title to a handful of healthcare providers each year   Chapel Hill, NC – On March 28, 2023, UNC’s MS/Neuroimmunology Division, a leading provider of care for people living with multiple sclerosis (MS), has been officially recognized as a Center for Comprehensive...

UNC Neurology is excited to announce Dr. Yen-Yu Ian Shih as its next Vice Chair for Research. Dr. Shih has over 10 years of research experience at UNC Neurology, joining the faculty in 2012 and appointed Associate Professor in 2017. Along with his position in Neurology, Dr. Shih has also...

Research at the University of North Carolina at Chapel Hill continues to grow, bringing in more than $1.2 billion in funding awards during the 2022 fiscal year. This is the third year in a row that research awards have topped $1 billion, facilitating research projects and experiments for external sponsors like...

The lab of Ian Shih, PhD, received the top prize from the journal NeuroImage for brain research featuring fMRI and fast-scan cyclic voltammetry. First author was Lindsay Walton, PhD.

UNC School of Medicine researchers led by Ian Shih, PhD, used fMRI and a genetic mouse model to study the effects of a neurotransmitter on brain network functional connectivity, a dynamic process crucial for human health and behavior.

James F. Howard, Jr, MD, in the UNC Department of Neurology is the lead primary investigator in the CHAMPION-MG trial for Ultomiris (ravulizumab-cwvz) as a treatment for adults with generalised myasthenia gravis who are anti-acetylcholine receptor antibody-positive, which represents 80% of people living with the disease.

James F. Howard Jr., MD, professor in the UNC Department of Neurology, was principal investigator of the ADAPT+ trial for the experimental drug efgartigimod, developed by Belgian pharmaceutical company Argenx.